Human Molecular Genetics Advance Access originally published online on April 27, 2006
Human Molecular Genetics 2006 15(11):1921-1930; doi:10.1093/hmg/ddl114
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells
1Department of Pediatrics, 2Herman B Wells Center for Pediatric Research and 3Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 1044 W. Walnut Street, R4/470 Indianapolis, IN 46202, USA
* To whom correspondence should be addressed. Tel: +1 3172788245; Fax: +1 3172748679; Email: dingram{at}iupui.edu
Received March 6, 2006; Accepted April 21, 2006
Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions as a negative regulator of Ras activity. NF1 patients develop renal artery stenosis and arterial occlusions resulting in cerebral and visceral infarcts. Further, NF1 patients develop vascular neurofibromas where tumor vessels are invested in a dense pericyte sheath. Although it is well established that aberrations in Ras signaling lead to human malignancies, emerging data generated in genetically engineered mouse models now implicate perturbations in the Ras signaling axis in vascular smooth muscular cells (VSMCs) as central to the initiation and progression of neointimal hyperplasia and arterial stenosis. Despite these observations, the function of neurofibromin in regulating VSMC function and how Ras signals are terminated in VSMCs is virtually unknown. Utilizing VSMCs harvested from Nf1+/– mice and primary human neurofibromin-deficient VSMCs, we identify a discrete Ras effector pathway, which is tightly regulated by neurofibromin to limit VSMC proliferation and migration. Thus, these studies identify neurofibromin as a novel regulator of Ras activity in VSMCs and provide a framework for understanding cardiovascular disease in NF1 patients and a mechanism by which Ras signals are attenuated for maintaining VSMC homeostasis in blood vessel walls.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Xu, F. A. Ismat, T. Wang, M. M. Lu, N. Antonucci, and J. A. Epstein Cardiomyocyte-Specific Loss of Neurofibromin Promotes Cardiac Hypertrophy and Dysfunction Circ. Res., July 31, 2009; 105(3): 304 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-K. Ku, H.-W. Chen, H.-W. Chen, C.-J. Fu, S.-C. Chin, and Y.-C. Liu Giant Extracranial Aneurysms of Both Internal Carotid Arteries with Aberrant Jugular Veins in a Patient with Neurofibromatosis Type 1 AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1750 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A G Cairns and K N North Cerebrovascular dysplasia in neurofibromatosis type 1 J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1165 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Lasater, W. K. Bessler, L. E. Mead, W. E. Horn, D. W. Clapp, S. J. Conway, D. A. Ingram, and F. Li Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway Hum. Mol. Genet., August 1, 2008; 17(15): 2336 - 2344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, F. A. Ismat, T. Wang, J. Yang, and J. A. Epstein NF1 Regulates a Ras-Dependent Vascular Smooth Muscle Proliferative Injury Response Circulation, November 6, 2007; 116(19): 2148 - 2156. [Abstract] [Full Text] [PDF]
|
|